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Abstract
AIM: To establish the hospitalized prevalence of se-
vere Crohn’s disease (CD) and ulcerative colitis (UC) in 
Wales from 1999 to 2007; and to investigate long-term 
mortality after hospitalization and associations with so-
cial deprivation and other socio-demographic factors.
METHODS: Record linkage of administrative inpatient 
and mortality data for 1467 and 1482 people hospital-
ised as emergencies for ≥ 3 d for CD and UC, respec-
tively. The main outcome measures were hospitalized 
prevalence, mortality rates and standardized mortality 
ratios for up to 5 years follow-up after hospitalization. 
RESULTS: Hospitalized prevalence was 50.1 per 
100 000 population for CD and 50.6 for UC. The hospi-
talized prevalence of CD was significantly higher (P  < 
0.05) in females (57.4) than in males (42.2), and was 
highest in people aged 16-29 years, but the prevalence 
of UC was similar in males (51.0) and females (50.1), 
and increased continuously with age. The hospital-
ized prevalence of CD was slightly higher in the most 
deprived areas, but there was no association between 
social deprivation and hospitalized prevalence of UC. 
Mortality was 6.8% and 14.6% after 1 and 5 years 
follow-up for CD, and 9.2% and 20.8% after 1 and 5 
years for UC. For both CD and UC, there was little dis-
cernible association between mortality and social dep-
rivation, distance from hospital, urban/rural residence 
and geography.
CONCLUSION: CD and UC have distinct demographic 
profiles. The higher prevalence of hospitalized CD in 
more deprived areas may reflect higher prevalence and 
higher hospital dependency.
© 2010 Baishideng. All rights reserved.
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INTRODUCTION
Inflammatory bowel disease (IBD), comprising mainly 
Crohn’s disease (CD) and ulcerative colitis (UC), can be 
one of  the most severe gastrointestinal disorders with 
a significant health and economic burden[1]. Presenting 
commonly in adolescence, IBD often results in debilitating 
morbidity and frequent relapses that impact heavily on 
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educational, social, professional and family life[1-3].
CD has increased in many countries in the past few 
decades, with highest prevalence often reported in west-
ern regions such as Northern and Western Europe and 
North America[3-7]. In the United Kingdom, the incidence 
of  UC has shown greater stability over time[6,8], while CD 
has continued to rise in many but not in all regions[7,9-13]. 
Most studies have reported that CD is more common in 
females than in males[8,10,11,13-16], whereas for UC, higher 
risks have been reported in females[3,17,18] or in males[2,19], as 
well as similar risks for females and males[20,21].
In the United Kingdom, the prevalence of  IBD is 
not known accurately, although based on regional stud-
ies, it is thought to affect approximately 150 000 peo-
ple[1]. Of  these, the majority have active IBD, with many 
having severe IBD that may lead to substantial inpatient 
stays. Our study focused on severe IBD, which we define 
as an emergency admission to hospital with a length of  
stay of  ≥ 3 d, because we wanted to study people who 
were acutely ill with severe IBD. Inclusion of  all patients 
admitted to hospital, regardless of  length of  stay, would 
have covered a wide spectrum of  disease severity, from 
elective day case investigation of  IBD and admissions 
for elective surgery, to emergency care of  patients who 
were severely ill with IBD.
Little is known about the prevalence of  severe IBD 
in the United Kingdom, how it varies geographically, and 
its relationship with social deprivation. Mortality follow-
ing hospitalization for IBD is significant[22], but few stud-
ies have been based on long-term follow-up. Additional-
ly, little is known about the effect on mortality of  social 
deprivation and other socio-demographic factors such as 
area of  residence and distance from hospital. These are 
important aspects of  the epidemiology of  IBD in the 
United Kingdom, which are important to understand in 
planning service provision and treatment. 
The main objective of  this study was to establish the 
prevalence of  UC and CD that was severe enough to re-
quire admission to hospital for ≥ 3 d, and to report on 
subsequent mortality after up to 5 years follow-up. Wales 
has a population of  3 million, and a mixed urban and ru-
ral geography, with areas of  significant social deprivation. 
Further objectives were to assess geographical variation in 
the hospitalized prevalence and mortality for CD and UC, 
and to investigate associations with social deprivation and 
other socio-demographic characteristics, including any 
association between mortality and distance of  patients’ 
residence from hospital and urban or rural residence.
MATERIALS AND METHODS
For this study, we used hospital inpatient data from the 
Patient Episode Database for Wales (PEDW), which 
incorporates medical record linkage to mortality data from 
the National Health Service Administrative Register[23]. 
PEDW is a comprehensive administrative database that 
covers all inpatient and day-case admissions to every 
National Health Service (NHS) hospital in Wales, and has 
been used as the basis for previously published studies[24-27]. 
It covers 17 district general or teaching hospitals in eight 
NHS hospital trusts across 22 health boards, and serves 
the Welsh population of  3 million. We used record linkage 
of  inpatient and mortality data because this enabled all 
repeat hospital admissions to be identified for the same 
patients, and enabled deaths following discharge from 
hospital to be identified, as well as in-hospital deaths.
The International Classification of  Diseases, 10th 
Edition (ICD-10) codes used were: K50 for CD and K51 
for UC. Patients with an emergency hospital admission of  
three or more consecutive days were classified as severe 
cases and included in the study. We selected only those 
admissions for which CD or UC was recorded as the 
principal diagnosis on the discharge record, and selected 
only the first admissions for each patient that met the 
study inclusion criteria during the 8-year study period 
from 1999 to 2007. We excluded all elective admissions, 
all day cases and inpatient admissions lasting < 3 d, all 
admissions subsequent to the first admission, and all 
admissions for which CD and UC were recorded on the 
discharge record as secondary diagnoses to other diseases 
such as colorectal malignancy. 
Hospitalized prevalence rates for CD and UC were 
calculated per 100 000 resident population, using the 
numbers of  severe hospitalized cases as the numerators 
and the Welsh residential population as the denominators. 
The direct method and the standard European population 
were used to standardize the prevalence rates. Mortality 
rates following hospital admission were calculated using 
the numbers of  deaths (from all causes) as the numerators, 
and the total number of  hospitalized cases, in the same 
time periods, as the denominators. Mortality rates were 
expressed as percentages and calculated at 1 and 5 years 
follow-up from the date of  hospital admission. 
To establish how mortality among the CD and UC 
patients compared with that in the general population, we 
used standardized mortality ratios (SMRs). These were 
calculated by applying the age- and sex-specific mortality 
rates in the general Welsh population to the numbers of  
study patients in the corresponding age- and sex-specific 
strata, to calculate the expected number of  deaths in the 
study patients, and by comparing the observed deaths 
with the expected deaths. 
Social deprivation scores were assigned to the patients’ 
place of  residence on each hospital record by using 
residential postcodes at the Lower Super Output Area 
(LSOA) and the Welsh Index of  Multiple Deprivation 
(WIMD) 2005[28]. The average population size of  the 1896 
LSOAs in Wales in 2005 was 1560. The WIMD 2005 was 
based on seven domains of  social deprivation: income, 
housing, employment, environment, health, access 
to services, and education. The LSOAs were ranked 
according to their WIMD 2005 score and grouped into 
quintiles, with quintile I representing the 20% of  least 
deprived LSOAs and quintile V the 20% of  most deprived 
LSOAs in Wales. 
Urban/rural residences were measured using five 
categories, based on settlement sizes that ranged from 
< 2500 to > 100 000 people. Distances from patients’ 
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residential LSOAs (geographical center points) to their 
hospital of  admission were calculated using ArcGIS 
Geographical Information System (GIS) software and 
were measured in five categories that ranged from < 3 to 
> 20 km. Other methods used included logistic regression 
analysis, χ2 tests, and Pearson’s correlations.
RESULTS
From 1999 to 2007, there were 1467 patients hospitalized 
for ≥ 3 d following emergency admission for CD (mean 
± SD, age: 45.8 ± 20.4 years) and 1482 for UC (mean ± 
SD, age: 52.0 ± 21.0 years). All the results that follow refer 
to these patients who meet the definition of  severe IBD, 
although, for brevity, we omitted the repeated use of  the 
term severe. 
Hospitalized prevalence of CD and UC 
The overall hospitalized prevalence rate per 100 000 
population was 50.1 for CD and 50.6 for UC (Table 1). 
Geographically, across the 22 health boards in Wales 
(Table 1), the prevalence of  Crohn’s varied from 31.5 per 
100 000 (95% CI: 22.6-42.7) to 71.3 (59.3-84.9), whereas 
for UC, it varied from 38.2 per 100 000 (29.6-48.5) to 89.7 
(66.6-118.3). 
For UC, there was a significant association between 
hospitalized prevalence and age (P < 0.05, Table 2). The 
hospitalized prevalence of  UC increased with age, and was 
highest for males and females aged > 65 years (103 and 
93.4 per 100 000, respectively). There was no significant 
association between the hospitalized prevalence of  CD 
and age. The highest age-specific prevalence of  CD was 
in the 16-29 years age group, for both males (61.4) and 
females (76.0). Overall, the hospitalized prevalence of  CD 
was significantly higher (P < 0.05) in females (57.4) than in 
males (42.2), whereas the hospitalized prevalence of  UC 
was very similar in females (50.1) and males (51.0, Table 2).
Figure 1 shows the geographical distribution of  the 
social deprivation quintiles to the 1896 LSOAs across 
Wales. The hospitalized prevalence of  CD was associated 
significantly with social deprivation at the LSOA level 
(Pearson’s correlation = 0.07, P = 0.004), although the 
association was not strong. The prevalence of  CD tended 
to be higher in more deprived areas, although there were 
not quite significant differences between the most and 
least affluent quintiles (Figure 2). For UC, there was no 
significant association between prevalence and social 
deprivation at the LSOA level, or across any of  the five 
social deprivation quintiles (Figure 2).
Mortality in CD and UC at 1 year
After 1 year follow-up, mortality was 6.8% for CD and 
9.2% for UC (Table 3). Corresponding SMRs at 1 year 
were 5.1 (95% CI: 4.1-6.27; compared with mortality of  1.0 
in the general population) for CD and 4.3 (95% CI: 3.6-5.1) 
for UC.
For CD and UC, mortality at 1 year increased sharply 
with age, and age-adjusted mortality was similar among 
males and females (Table 3). Very few deaths occurred 
among people aged < 45 years. For CD and UC, there 
was no significant variation in mortality according to 
social deprivation, urban/rural residence, distance from 
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Table 1  Hospitalized prevalence of severe CD and ulcerative colitis across health boards, 1999-2007







95% CI Cases Prevalence
(per 100 000)
95% CI
Blaenau Gwent 1 47 33.8 ± 12.7 31 44.7 (30.4-63.5) 27 39.0 (25.7-56.7)
Bridgend 2 85 23.2 ± 13.0 41 31.5 (22.6-42.7) 62 47.6 (36.5-61.0)
Caerphilly 3 110 27.0 ± 14.1 97 57.0 (46.2-69.5) 91 53.5 (43.0-65.6)
Cardiff 4 203 21.3 ± 18.0 158 50.9 (43.3-59.5) 137 44.1 (37.1-52.2)
Carmarthenshire 5 112 22.0 ± 10.3 125 71.3 (59.3-84.9) 67 38.2 (29.6-48.5)
Ceredigion 6 47 15.0 ± 6.2 35 46.0 (32.0-63.9) 30 39.4 (26.6-56.2)
Conwy 7 71 18.0 ± 11.0 64 57.8 (44.5-73.8) 84 75.9 (60.6-94.0)
Denbighshire 8 58 20.4 ± 15.6 56 59.0 (44.6-76.7) 56 59.0 (44.6-76.7)
Flintshire 9 92 15.0 ± 10.2 74 49.6 (38.9-62.2) 77 51.6 (40.7-64.5)
Gwynedd 10 75 17.3 ± 7.4 63 53.7 (41.2-68.7) 70 59.6 (46.5-75.4)
Isle of Anglesey 11 44 20.7 ± 8.8 43 63.0 (45.6-84.9) 43 63.0 (45.6-84.9)
Merthyr Tydfil 12 36 37.2 ± 17.0 26 46.7 (30.5-68.4) 50 89.7   (66.6-118.3)
Monmouthshire 13 58 12.2 ± 6.0 37 42.9 (30.2-59.1) 44 51.0 (37.1-68.5)
Neath Port Talbot 14 91 28.2 ± 14.4 76 56.0 (44.1-70.0) 53 39.0 (29.2-51.0)
Newport 15 94 22.0 ± 15.6 73 52.4 (41.1-65.9) 71 51.0 (39.8-64.3)
Pembrokeshire 16 71 19.4 ± 8.9 44 38.0 (27.6-51.0) 47 40.6 (29.8-54.0)
Powys 17 80 14.3 ± 6.1 44 34.2 (24.9-46.0) 62 48.2 (37.0-61.8)
Rhondda Cynon Taff 18 152 29.2 ± 15.4 116 50.0 (41.3-60.0) 125 53.9 (44.9-64.2)
Swansea 19 147 22.6 ± 17.8 101 44.9 (36.6-54.6) 109 48.5 (39.8-58.5)
Torfaen 20 60 21.3 ± 10.8 46 50.6 (37.1-67.5) 51 56.1 (41.8-73.8)
Vale of Glamorgan 21 78 15.0 ± 10.5 49 40.7 (30.1-53.7) 74 61.4 (48.2-77.1)
Wrexham 22 85 19.9 ± 13.5 68 52.5 (40.8-66.5) 52 40.2 (30.0-52.6)
All Wales 1896 21.7 ± 14.3 1467 50.1 (47.5-52.7) 1482 50.6 (48.0-53.2)
1For geographical details of each health board, see Figure 1. CD: Crohn's disease; UC: Ulcerative colitis; LSOA: Lower Super Output Area.
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Table 2  Age- and sex-specific hospitalized prevalence rates for severe CD and UC, 1999-2007
hospital, and whether or not an emergency colectomy was 
performed (Table 3). Although there was some variation 
in mortality across the 22 Welsh health boards, there 
were no significant differences between individual health 
boards. 
Mortality in CD and UC at 5 years
Mortality at 5 years was 14.6% for CD and 20.8% for 
UC (Table 4). SMRs at 5 years were 2.4 (95% CI: 1.9-2.9; 
compared with mortality of  1.0 in the general population) 
for CD and 1.9 (95% CI: 1.5-2.2) for UC.
For CD and UC, mortality at 5 years was comparable 
among females and males, and it increased sharply among 
older age groups: among men aged > 65 years and women 
aged > 60 years, mortality was 34% for CD and 49% for 
UC (Table 4). There were no significant differences in 
mortality at 5 years according to urban/rural residence, 
distance travelled to hospital, or whether an emergency 
colectomy was performed (Table 4). For CD, mortality 
was significantly higher in the most deprived quintile 
compared with the second most affluent quintile, although 
there were no other significant differences in mortality 
according to social deprivation. 
DISCUSSION
The main aims of  this record linkage study were to 
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CD UC
Cases Prevalence (per 100 000) 95% CI Cases Prevalence (per 100 000) 95% CI
Males All 601 42.2 (38.9-45.8) 726 51.0 (47.4-54.9)
  0-15 25 8.4 (5.5-12.5) 20 6.7 (4.1-10.4)
16-29 151 61.4 (52.0-72.0) 115 46.7 (38.6-56.1)
30-44 141 47.6 (40.1-56.1) 168 56.7 (48.5-66.0)
45-64 163 44.5 (38.0-51.9) 199 54.4 (47.1-62.5)
65+ 119 54.5 (45.2-65.3) 224 103 (89.7-117)
Females All 866 57.4 (53.7-61.4) 756 50.1 (46.6-53.8)
  0-15 21 7.5 (4.6-11.4) 11 3.9 (2.0-7.0)
16-29 185 76.0 (65.5-87.8) 114 46.9 (38.6-56.3)
30-44 232 74.3 (65.1-84.5) 166 53.2 (45.4-61.9)
45-64 222 58.9 (51.4-67.2) 189 50.1 (43.3-57.8)
65+ 205 69.4 (60.2-79.6) 276 93.4 (82.7-105)
All Wales 1467 50.1 (47.5-52.7) 1482 50.6 (48.0-53.2)
The ages of three Crohn’s patients, two males and one female, was unknown.
Figure 2  Hospitalized prevalence of severe Crohn’s disease and ulcerative 
colitis according to social deprivation, 1999-2007. I: Least deprived social 
deprivation quintile; V: Most deprived. Vertical bars represent 95% CI. These 
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         Social deprivation quintiles
Figure 1  WIMD 2005 quintiles for the 22 health boards and the 1896 
geographical LSOAs in Wales. The key to the health board numbering is as 
follow: 1 Blaenau Gwent; 2 Bridgend; 3 Caerphilly; 4 Cardiff; 5 Carmarthenshire; 
6 Ceredigion; 7 Conwy; 8 Denbighshire; 9 Flintshire; 10 Gwynedd; 11 Isle 
of Anglesey; 12 Merthyr Tydfil; 13 Monmouthshire; 14 Neath Port Talbot; 15 
Newport; 16 Pembrokeshire; 17 Powys; 18 Rhondda Cynon Taff; 19 Swansea; 20 
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Table 3  Mortality at 1 year following hospitalization for severe CD and UC, 1999-2007
establish the extent and prognosis of  severe CD and UC in 
Wales, and how they are associated with social deprivation, 
geography and other socio-demographic aspects. It is 
thought that IBD affects approximately 150 000 people 
in the United Kingdom, with corresponding prevalence 
rates of  55-140 per 100 000 for CD, 160-240 per 100 000 
for UC, and approximately 13 300 combined new cases 
diagnosed each year[1]. We found a hospitalized prevalence 
rate of  50.1 per 100 000 population for severe CD and 
50.6 for severe UC. If  these prevalence rates for Wales 
were applied to the whole of  the United Kingdom, this 
would suggest a total of  approximately 62 000 people 
hospitalized with severe IBD over the 9-year study period 
(30 000 for CD and 32 000 for UC). 
The main strength of  this study was its size, which 
covered almost 3000 patients who were hospitalized for 
IBD in a geographically defined population of  nearly 3 
million over a 8-year period. Further strengths are that it 
was based on systematic record linkage, which enabled 
long-term mortality follow-up of  5 years, by monitoring 
deaths that occurred in and following discharge from 
hospital. The study also used geographical measures 
of  social deprivation to measure social inequality comp-
rehensively on a national scale, as well as other novel 
prognostic/demographic risk factors, such as distance 
from home to hospital and urban or rural residences. 
We defined severe IBD as emergency hospitalization 
for IBD, as the principal reason for admission, which lasted 
≥ 3 d. This was to distinguish severe illness from relatively 
minor illness and from day-case investigations. We accept 
that the definition may also have included some patients 
who were admitted with long stays for other serious 
illnesses, for example, myocardial infarction or pneumonia, 
who also had IBD. However, we sought to minimize this 
by restricting case selection to people in whom IBD itself  
was coded as the principal reason for admission. 
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CD UC








All 1261 86 6.8 1300 119 9.2
Age groups by gender
Male All 506 30 5.9 633 50 7.9
0-15 22 0 0.0 16 0 0.0
16-29 128 0 0.0 101 0 0.0
30-44 119 1 0.8 145 0 0.0
45-64 136 5 3.7 172 7 4.1
65+ 99 24 24.2 199 43 21.6
Female All 755 56 7.4 667 69 10.3
0-15 19 0 0.0 8 0 0.0
16-29 165 2 1.2 96 0 0.0
30-44 202 5 2.5 151 3 2.0
45-64 189 7 3.7 169 8 4.7
65+ 179 42 23.5 243 58 23.9
Sex
   Male 504 30 6.0 Ref. 633 50 7.9 Ref.
   Female 754 56 7.4 1.05 (0.63-1.74) 667 69 10.3 1.03 (0.67-1.57)
Colectomy performed
   Yes 193 9 4.7 Ref. 162 17 10.5 Ref.
   No 1068 77 7.2 1.59 (0.74-3.41) 1138 102 9.0 0.57 (0.31-1.05)
Social deprivation
   Ⅰ	(least deprived) 229 16 7.0 0.99 (0.45-2.17) 234 20 8.5 0.83 (0.42-1.65)
   Ⅱ 236 10 4.2 0.49 (0.21-1.18) 245 21 8.6 0.89 (0.45-1.76)
   Ⅲ 257 23 8.9 1.23 (0.60-2.55) 282 27 9.6 0.86 (0.46-1.61)
   Ⅳ 277 20 7.2 0.85 (0.41-1.77) 280 27 9.6 0.99 (0.52-1.86)
   Ⅴ  (most deprived) 262 17 6.5 Ref. 259 24 9.3 Ref.
Urban/rural residence
   Under 2500 people 256 17 6.6 Ref. 277 22 7.9 Ref.
   2500-9999 205 13 6.3 0.76 (0.33-1.76) 222 21 9.5 1.29 (0.64-2.59)
   10 000-24 999 278 26 9.4 1.48 (0.72-3.06) 280 24 8.6 1.17 (0.60-2.30)
   25 000-99 999 260 15 5.8 0.71 (0.32-1.60) 274 28 10.2 1.48 (0.77-2.85)
   At least 100 000 262 15 5.7 0.67 (0.29-1.54) 247 24 9.7 1.58 (0.80-3.14)
Distance from hospital
   < 3 km 187 14 7.5 Ref. 211 21 10.0 Ref.
   3-4.99 km 145 6 4.1 0.55 (0.19-1.59) 159 14 8.8 0.97 (0.44-2.10)
   5-9.99 km 269 18 6.7 1.03 (0.46-2.31) 285 25 8.8 0.91 (0.47-1.76)
   10-19.99 km 318 22 6.9 1.14 (0.52-2.49) 303 30 9.9 0.94 (0.49-1.80)
   ≥ 20 km 207 16 7.7 1.14 (0.49-2.65) 206 19 9.2 1.03 (0.50-2.13)
1The OR for sex is adjusted for age group. The OR for social deprivation and colectomy was adjusted for age group and sex. The adjusted OR for urban/
rural residence and distance from hospital was adjusted for age group, sex and social deprivation.
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The main limitation of  record linkage studies such 
as this is the lack of  detailed information about the 
history, severity and management of  the illness. It was 
not possible to ascertain the extent of  disease from 
endoscopic evidence or detailed pathology information 
from our data sources. Our hospitalized prevalence rates 
referred specifically to CD and UC patients with an 
inpatient stay of  ≥ 3 d following emergency admission. 
Although length of  stay is often affected by factors such 
as age, comorbidity, and effectiveness of  self  care and 
social support, we believe that a length of  stay of  ≥ 3 d 
after emergency admission usually indicates severe disease 
that requires intensive medical or surgical treatment rather 
than admission for diagnosis or assessment.
For both males and females, we found a continuous 
rise in the hospitalized prevalence of  UC as age increased. 
For CD, we found highest prevalence among patients aged 
16-29 years, with a second peak in prevalence in males 
aged > 65 years and females aged ≥ 60 years. We also 
found a higher prevalence of  CD in females than in males, 
but a similar prevalence of  UC among males and females, 
which is consistent with other studies[8,10,11,13,14,16,19,29].
IBD has been linked with higher socioeconomic 
groups in some studies, particularly for CD[30,31], but 
also for UC[31], although other studies have reported 
no association[32-34]. Instead, we found slightly higher 
hospitalized prevalence of  CD in more socially deprived 
locations, although there were not quite significant 
differences across the social deprivation quintiles. As our 
study focused on more severe cases, possible reasons for 
this include higher levels of  health-care dependency as 
well as higher levels of  smoking and more comorbidity 
among patients from more deprived social backgrounds. 
For UC, we found no significant association between 
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Table 4  Mortality at 5 years following hospitalization for severe Crohn’s disease and ulcerative colitis, 1999-2007
CD UC












All 535 78 14.6 567 118 20.8
Age groups by sex
Male All 209 28 13.4 275 55 20.0
0-15 10 0 0.0 5 0 0.0
16-29 50 0 0.0 43 1 2.3
30-44 52 2 3.8 73 0 0.0
45-64 58 8 13.8 63 4 6.3
65+ 39 18 46.2 91 50 54.9
Female All 326 50 15.3 292 63 21.6
0-15 9 0 0.0 4 0 0.0
16-29 72 1 1.4 40 1 2.5
30-44 91 3 3.3 59 2 3.4
45-64 84 10 11.9 86 6 7.0
65+ 70 36 51.4 103 54 52.4
Sex
   Male 209 28 13.4 Ref. 275 55 20.0 Ref.
   Female 326 50 15.3 0.96 (0.52-1.76) 292 63 21.6 0.76 (0.44-1.31)
Colectomy performed
   Yes 89 10 11.2 Ref. 72 15 20.8 Ref.
   No 446 68 15.2 1.48 (0.63-3.52) 495 103 20.8 0.59 (0.26-1.33)
Social deprivation
   Ⅰ (least deprived) 110 14 12.7 0.53 (0.20-1.39) 110 24 21.8 1.39 (0.61-3.19)
   Ⅱ 102 9 8.8 a0.23 (0.08-0.68) 110 19 17.3 0.85 (0.35-2.05)
   Ⅲ 112 16 14.3 0.56 (0.21-1.46) 114 31 27.2 1.62 (0.73-3.58)
   Ⅳ 106 21 19.8 1.09 (0.45-2.68) 112 23 20.5 1.29 (0.55-3.02)
   Ⅴ (most deprived) 105 18 17.1 Ref. 121 21 17.4 Ref.
Urban/rural residence 
   Under 2500 people 103 11 10.7 Ref. 124 28 22.6 Ref.
   2500-9999 89 16 18.0 1.42 (0.49-4.12) 105 22 21.0 0.64 (0.26-1.53)
   10 000-24 999 124 21 16.9 1.32 (0.49-3.56) 109 18 16.5 0.47 (0.19-1.17)
   25 000-99 999 99 15 15.2 0.75 (0.26-2.14) 121 26 21.5 0.86 (0.37-1.97)
   ≥ 100 000 120 15 12.5 0.89 (0.31-2.54) 108 24 22.2 0.84 (0.35-1.98)
Distance from hospital
   < 3 km 87 14 16.1 Ref. 101 24 23.8 Ref.
   3-4.99 km 73 9 12.3 0.52 (0.16-1.63) 67 14 20.9 0.80 (0.31-2.09)
   5-9.99 km 111 12 10.8 0.71 (0.25-2.01) 123 22 17.9 0.80 (0.35-1.85)
   10-19.99 km 135 17 12.6 0.81 (0.30-2.19) 112 27 24.1 0.97 (0.41-2.29)
   ≥ 20 km 70 15 21.4 1.26 (0.42-3.78) 87 16 18.4 0.78 (0.31-2.00)
aP < 0.01. 1The OR for sex was adjusted for age group. The OR for social deprivation and colectomy was adjusted for age group and sex. The adjusted OR 
for urban/rural residence and distance from hospital was adjusted for age group, sex and social deprivation; 2Fewer people had 5 years than 1 year follow-
up during the 9-year study period, therefore, the number of cases was lower in this Table than in Table 3.
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hospitalized prevalence and social deprivation. The 
differing demographic profiles between CD and UC, and 
the stronger evidence of  an association between CD and 
social deprivation suggests that environmental factors 
play a stronger part in the etiology of  CD, but attempts to 
establish environmental factors have proved inconclusive 
and sometimes controversial in the past[31,33-37]. 
Overall mortality was 6.8% at 1 year and 14.6% at 5 
years for CD, compared with 9.2% at 1 year and 20.8% 
at 5 years for UC. At 5 years, mortality was high among 
older patients (49% and 54% for CD and UC, respectively, 
among patients aged ≥ 65 years). The higher mortality for 
UC is consistent with other studies[16,22,38], although there 
is a lack of  large studies with long-term follow-up for 
people hospitalized with IBD. Mortality at 1 year follow-
up was five times higher than in the general population for 
CD and four times higher for UC. At 5 years, mortality 
was increased two fold for CD and UC. An earlier study 
has reported SMRs of  3.2 and 2.4 after 3 years follow-
up for people hospitalized with severe CD and UC, 
respectively, in England[22], and further demonstrates that 
people hospitalized with severe IBD are often at increased 
risk of  mortality, which continues in the long term. 
Elective colectomy may well be the most effective means 
of  reducing these excess risks of  mortality[22].
Although there was some variation in prognosis 
geographically across health boards, it was not significant 
for either CD or UC. We also found little discernible 
association between social deprivation quintiles, distance 
travelled to hospital and rural versus urban residence, 
and subsequent mortality at either 1 or 5 years. As IBD 
often relapses and requires regular monitoring and 
surveillance, it is possible that patients who live remotely 
from outpatient clinics and hospital care may have poorer 
outcomes. Our findings for mortality outcomes do not 
support such concerns, although recent health service 
developments in the United Kingdom that encourage 
greater management and treatment of  IBD in primary 
care may partially offset the distances travelled by patients. 
We found that severe CD and UC had quite distinct 
demographic profiles in Wales. CD and UC also showed 
slightly differing patterns of  association with social 
deprivation. The higher prevalence of  hospitalized 
CD in more deprived areas may reflect higher smoking 
rates, more comorbidity and higher levels of  hospital 
dependency, as well as higher prevalence.
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recent decades. Although inflammatory bowel disease (IBD) is thought to affect 
about 150 000 people in the United Kingdom, the prevalence of severe IBD is 
not known. Mortality following hospitalization for IBD is significant but little has 
been reported on long-term follow-up.
Research frontiers
This study determined the hospitalized prevalence of severe IBD and 
subsequent 5-year mortality in Wales, and investigates associations between 
severe IBD and social deprivation, distance travelled to hospital, and other 
socio-demographic characteristics.
Innovations and breakthroughs
This study showed that the hospitalized prevalence of severe CD was slightly 
higher among the most deprived groups but there was no association between 
social deprivation and severe ulcerative colitis (UC). Five-year mortality was 
high for severe CD (14.6%) and UC (20.8%), but there was little association 
between mortality and social deprivation, distance from hospital, urban/rural 
residences or geography.   
Applications 
The higher hospitalized prevalence of severe CD among the most deprived 
groups, and differing demographic profiles between CD and UC, suggest that 
environmental factors play a more significant role in the etiology of CD. The 
findings of this large population-based study on the prevalence and mortality of 
IBD are also important for service planning and provision.
Terminology
Hospitalized prevalence of severe IBD in this study referred to the number of 
people (per 100 000 population) who were hospitalized as an emergency for ≥ 3 
d for IBD, as the principal reason for admission, on at least one occasion during 
the 8-year study period. One and five-year mortality referred to the percentage of 
these people who died during the subsequent  one and five-year follow-up period.
Peer review
This was a well-conducted, large epidemiological study that provided interesting 
and novel findings. For example, the findings that distance travelled by patients 
to hospital did not affect long-term mortality for CD or UC has not been reported 
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